Bone Grafts and Substitutes Market Size, Segments and Insights

The global market for bone grafts and substitutes was valued at approximately US$ 2.99 billion in 2023. It is expected to grow significantly, reaching an estimated US$ 5.95 billion by 2034, with a compound annual growth rate (CAGR) of 6.45% from 2024 to 2034.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5227

Here are the key insights rephrased

• In 2023, North America held the largest market share at 43%.
• The Asia Pacific region is expected to grow the fastest, with a projected growth rate of 6.04% during the forecast period.
• The allograft material segment was the largest in 2023, accounting for 57% of the market.
• The synthetic material segment is anticipated to grow at the fastest rate from 2024 to 2034.
• The spine fusion application was the leading segment in the bone grafts and substitutes market in 2023.
• The dental application is expected to experience the fastest growth during the forecast period.

Leading Companies in the Bone Grafts and Substitutes Market

• AlloSource: A nonprofit organization specializing in providing human tissue allografts for medical use, including bone grafts and substitutes.
• Biogennix: Known for its advanced biomaterial solutions in bone grafting, Biogennix develops synthetic and regenerative bone substitutes.
• OST Laboratories: Specializes in providing bone grafting solutions, focusing on the research and development of innovative technologies.
• Biobank: A leading provider of human tissue-based products, offering a wide range of bone grafts for various medical applications.
• Paradigm BioDevices, Inc.: Focuses on developing advanced bioresorbable implants and substitutes for bone grafting, improving healing processes.
• Smith + Nephew: A global medical technology company, Smith + Nephew provides bone grafts, joint reconstruction, and wound care products.
• NuVasive, Inc.: Specializes in minimally invasive spine surgery technologies and bone graft products designed to support spinal fusion procedures.
• DePuy Synthes (Johnson & Johnson Inc.): A leader in the orthopedic and spinal market, DePuy Synthes offers a broad portfolio of bone grafts, including synthetic and biologic options.
• TBF: A company that focuses on providing high-quality bone graft substitutes and materials for a range of orthopedic applications.
• Orthofix US LLC: Known for its orthopedic and spinal solutions, Orthofix offers bone graft substitutes and medical devices for bone healing.
• Baxter: A global healthcare company providing a variety of medical products, including bone grafts, with a focus on regenerative medicine.
• Stryker: A major player in the medical technology field, Stryker offers a wide range of orthopedic and bone grafting products, including those for joint and spine surgery.
• Zimmer Biomet: A leading global company in musculoskeletal healthcare, Zimmer Biomet develops bone grafts and substitutes to support joint and spine health.
• Medtronic: Known for its medical technologies, Medtronic offers a variety of orthopedic solutions, including bone graft products for spinal and trauma procedures.
• Geistlich Pharma AG: Specializes in regenerative medicine, particularly in bone graft substitutes, providing high-quality biomaterials for dental and orthopedic applications.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/bone-grafts-and-substitutes-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5227

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare